Chemokine ligand 18 (CCL18) is another interesting molecule in the fibrotic process of SSc-ILD; while its role is not yet fully understood, it seems to drive fibroblast proliferation and collagen production, and its levels are increased in BALF of SSc-ILD patients [6,7]. This evidence concerns the gene CCL18 and systemic sclerosis.